MedTrace Logo

MMRF Molecular Profiling Protocol

NCT02884102 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-05-06

No results posted yet for this study

Summary

This protocol is now being used as screening for the MyDRUG study

Conditions

Interventions

GENETIC

genetic sequencing

Sponsors & Collaborators

  • Multiple Myeloma Research Foundation

    lead OTHER

Principal Investigators

  • Leif Bergsagel, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02884102 on ClinicalTrials.gov